These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10790589)

  • 1. Growth hormone-releasing peptides and the cardiovascular system.
    Muccioli G; Broglio F; Valetto MR; Ghè C; Catapano F; Graziani A; Papotti M; Bisi G; Deghenghi R; Ghigo E
    Ann Endocrinol (Paris); 2000 Feb; 61(1):27-31. PubMed ID: 10790589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone-releasing peptides.
    Ghigo E; Arvat E; Muccioli G; Camanni F
    Eur J Endocrinol; 1997 May; 136(5):445-60. PubMed ID: 9186261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.
    Arvat E; Di Vito L; Lanfranco F; Broglio F; Giordano R; Benso A; Muccioli GP; Deghenghi R; Ghigo E
    J Endocrinol Invest; 1999 Feb; 22(2):91-7. PubMed ID: 10195374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History to the discovery of ghrelin.
    Bowers CY
    Methods Enzymol; 2012; 514():3-32. PubMed ID: 22975043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor.
    Gondo RG; Aguiar-Oliveira MH; Hayashida CY; Toledo SP; Abelin N; Levine MA; Bowers CY; Souza AH; Pereira RM; Santos NL; Salvatori R
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3279-83. PubMed ID: 11443201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for growth hormone-releasing peptide.
    Ong H; Bodart V; McNicoll N; Lamontagne D; Bouchard JF
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():137-40. PubMed ID: 10990149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart.
    Bodart V; Bouchard JF; McNicoll N; Escher E; Carrière P; Ghigo E; Sejlitz T; Sirois MG; Lamontagne D; Ong H
    Circ Res; 1999 Oct; 85(9):796-802. PubMed ID: 10532947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human fetal pituitary expresses functional growth hormone-releasing peptide receptors.
    Shimon I; Yan X; Melmed S
    J Clin Endocrinol Metab; 1998 Jan; 83(1):174-8. PubMed ID: 9435437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency.
    Maheshwari HG; Rahim A; Shalet SM; Baumann G
    J Clin Endocrinol Metab; 1999 Mar; 84(3):956-9. PubMed ID: 10084578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.
    Muccioli G; Ghè C; Ghigo MC; Papotti M; Arvat E; Boghen MF; Nilsson MH; Deghenghi R; Ong H; Ghigo E
    J Endocrinol; 1998 Apr; 157(1):99-106. PubMed ID: 9614363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
    Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
    Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy.
    Broglio F; Benso A; Valetto MR; Gottero C; Quaranta L; Podio V; Arvat E; Bobbio M; Bisi G; Ghigo E
    Endocrine; 2001 Feb; 14(1):105-8. PubMed ID: 11322491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Gianotti L; Broglio F; Benso A; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1998 May; 67(5):310-6. PubMed ID: 9641612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations.
    Arvat E; Ramunni J; Bellone J; Di Vito L; Baffoni C; Broglio F; Deghenghi R; Bartolotta E; Ghigo E
    Eur J Endocrinol; 1997 Dec; 137(6):635-42. PubMed ID: 9437229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone.
    Bercu BB; Yang SW; Masuda R; Walker RF
    Endocrinology; 1992 May; 130(5):2579-86. PubMed ID: 1315249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic activities of growth hormone secretagogues in humans.
    Ghigo E; Arvat E; Giordano R; Broglio F; Gianotti L; Maccario M; Bisi G; Graziani A; Papotti M; Muccioli G; Deghenghi R; Camanni F
    Endocrine; 2001 Feb; 14(1):87-93. PubMed ID: 11322506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland.
    Deghenghi R; Papotti M; Ghigo E; Muccioli G; Locatelli V
    Endocrine; 2001 Feb; 14(1):29-33. PubMed ID: 11322499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
    Ghè C; Cassoni P; Catapano F; Marrocco T; Deghenghi R; Ghigo E; Muccioli G; Papotti M
    Endocrinology; 2002 Feb; 143(2):484-91. PubMed ID: 11796502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an opiate antagonist on the hormonal changes induced by hexarelin.
    Korbonits M; Trainer PJ; Besser GM
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):365-71. PubMed ID: 7586608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.